16-8735795-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020686.6(ABAT):c.56G>T(p.Arg19Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R19C) has been classified as Likely benign.
Frequency
Consequence
NM_020686.6 missense
Scores
Clinical Significance
Conservation
Publications
- GABA aminotransaminase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Orphanet, G2P
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020686.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ABAT | NM_020686.6 | MANE Select | c.56G>T | p.Arg19Leu | missense | Exon 2 of 16 | NP_065737.2 | ||
| ABAT | NM_001386615.1 | c.56G>T | p.Arg19Leu | missense | Exon 2 of 17 | NP_001373544.1 | |||
| ABAT | NM_001386616.1 | c.56G>T | p.Arg19Leu | missense | Exon 2 of 16 | NP_001373545.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ABAT | ENST00000268251.13 | TSL:1 MANE Select | c.56G>T | p.Arg19Leu | missense | Exon 2 of 16 | ENSP00000268251.8 | ||
| ABAT | ENST00000569156.5 | TSL:1 | c.56G>T | p.Arg19Leu | missense | Exon 2 of 16 | ENSP00000454963.1 | ||
| ABAT | ENST00000566590.5 | TSL:1 | n.56G>T | non_coding_transcript_exon | Exon 2 of 15 | ENSP00000455198.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1451710Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 721154
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Gamma-aminobutyric acid transaminase deficiency Uncertain:1
This sequence change replaces arginine with leucine at codon 19 of the ABAT protein (p.Arg19Leu). The arginine residue is weakly conserved and there is a moderate physicochemical difference between arginine and leucine. This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with ABAT-related conditions.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at